首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2020年 6期“非酒精性脂肪性肝病与多代谢紊乱的基础与临床” => 专家论坛 =>核受体在非酒精性脂肪..
核受体在非酒精性脂肪性肝病发病机制和药物开发中的应用
Application of nuclear receptor in pathogenesis research and drug development for nonalcoholic fatty liver disease
文章发布日期:2020年06月01日  来源:  作者:陈轶妍,陆炎  点击次数:210次  下载次数:76次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:非酒精性脂肪性肝病(NAFLD)是发达国家最常见的肝病,近年来在我国发病率呈现上升趋势,对社会卫生系统造成一定负担。NAFLD发生发展过程受到遗传和表观遗传、转录因子和激素、营养和环境等多重影响因素的相互作用。简要探讨了核受体在NAFLD发生机制中的研究进展,以加深对该疾病的理解和认识。
【Abstract】:Nonalcoholic fatty liver disease (NAFLD) is the most common type of liver disease in developed countries, and in recent years, the prevalence rate of NAFLD tends to increase in China, which brings heavy burden to the social health system. The development and progression of NAFLD are affected by the interaction between multiple influencing factors including genetic and epigenetic factors, transcription factors, hormones, nutrition, and environmental factors. This article reviews the research advances in the role of nuclear receptor in the pathogenesis of NAFLD, in order to deepen the understanding of this disease.
【关键字】:非酒精性脂肪性肝病; 核受体; 分子靶向治疗
【Key words】:non-alcoholic fatty liver disease; nuclear receptors; molecular targeted therapy
【引证本文】:CHEN YY, LU Y. Application of nuclear receptor in pathogenesis research and drug development for nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2020, 36(6): 1221-1223. (in Chinese)
陈轶妍, 陆炎. 核受体在非酒精性脂肪性肝病发病机制和药物开发中的应用[J]. 临床肝胆病杂志, 2020, 36(6): 1221-1223.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号